Search Results (106)

Electroporation outcomes are governed by the local electric field distribution and transmembrane voltage, both of which may be altered by nanoscale elements positioned near the cell membrane. In this study, we developed a two-dimensional finite-element electromagnetic model to investigate the effect of a membrane-proximal silica-coated superparamagnetic iron oxide nanoparticle cluster during a trapezoidal electroporation pulse. The model couples electric and magnetic field components with a membrane electroporation formulation based on Smoluchowski-type pore-density dynamics. Simulations were performed with and without a nanoparticle positioned 5 nm from the membrane, considering different cytosol and extracellular medium conductivities. The results show that the nanoparticle induces a highly localized perturbation of the electric field, whose magnitude depends on the sampling region and conductivity contrast. Transmembrane voltage is modestly and transiently modulated during pulse rise time, whereas the effect is limited during the pulse plateau. Pore-density analysis further indicates that the nanoparticle does not induce a generalized increase in electroporation-related parameters and may locally reduce pore density near the nanoparticle–membrane interface. Overall, the model identifies transient and conductivity-dependent nanoscale field redistribution caused by membrane-proximal silica-coated magnetic nanoparticles, while highlighting the need for three-dimensional modeling and experimental validation before inferring electroporation enhancement. Full article

Mitochondria-targeting metal complexes (MTMCs) are a mechanistically distinct class of metallopharmaceuticals. Unlike first-generation platinum drugs that form nuclear DNA adducts, MTMCs exploit organelle-specific vulnerabilities such as hyperpolarised mitochondrial membrane potential (ΔΨm), elevated reactive oxygen species (ROS), limited mitochondrial DNA (mtDNA) repair capacity, and redox-dependent enzymes such as thioredoxin reductase (TrxR). We systematically searched PubMed, Web of Science, Scopus, and Google Scholar databases for studies published between 2016 and 2026, applying predefined inclusion criteria that included subcellular localization evidence and functional bioenergetic endpoints. The search identified 147 studies covering Pt(II/IV), Ru(II/III), Au(I/III), Ir(III), Os(II), Re(I), and V(IV/V) complexes and metal–organic framework nanoplatforms. Mechanistic evidence converges on four intramitochondrial target categories: inhibition of ETC (Electron Transport Chain) Complexes I/III with consequent ATP depletion; ROS overproduction, coupled with glutathione and TrxR depletion; outer mitochondrial membrane permeabilization and intrinsic apoptotic cascade activation; and mtDNA damage within a compartment limited to base excision repair. Multi-modal cell death—the co-occurrence of apoptosis, ferroptosis, necroptosis, and autophagic cell death—was a recurrent finding across the reviewed studies. This review thoroughly surveys the latest trends in MTMC drug design (metals, ligand structures, and mechanisms of action) and summarises analytical techniques for speciation, pharmacokinetics, safe monitoring, and resistance, while critically analysing translational barriers and clinical failures. To address the field’s inconsistent terminology, we introduce an explicit localization evidence hierarchy that distinguishes mitochondria-targeting complexes (through quantitative ICP-MS fractionation or co-localization with defined Pearson/Manders coefficients) from simply mitochondria-localising or mitochondria-perturbing agents, and we apply it throughout. We also point out that the idea of selectivity being purely driven by membrane voltage (ΔΨm) and thermodynamics is constrained by membrane and protein binding, as well as the transmembrane pH gradient, kinetic limitations, and demonstrated heterogeneity of cancer-cell membrane potential, and, as such, the functional mitochondrial effects must not be equated with mitochondrial accumulation. Since elemental quantification cannot distinguish intact complex from protein adducts and decomposition products, speciation-aware pharmacokinetics emerges as a prerequisite for a credible exposure–response interpretation. The translational progress will depend less on new chemotypes than on this analytical and pharmacokinetic rigour, together with organelle-level safety monitoring and biomarker-guided patient selection. Full article

Ion channels are validated drug targets, but they remain difficult to study as their pharmacology is influenced by rapid gating, conformational state transitions, cell-type-specific expression, and narrow safety margins. Recent advances in cryo-electron microscopy, structure-based in silico screening, machine-learning-guided prioritization, optical high-throughput screening, automated patch-clamp electrophysiology, and human-relevant organoid or microphysiological system (MPS) models are transforming this field. In this expanded review, we examine how these modalities can be integrated into a hybrid discovery pipeline that begins with computational triage, proceeds through scalable functional screening and state-aware electrophysiological validation, and concludes with multi-channel safety de-risking and translational analysis in complex human models. We also discuss disease-associated channel remodeling in cancer and inflammatory disorders, with an emphasis on transient receptor potential channels, voltage-gated potassium channel 1.3 (Kv1.3), Piezo channels, transmembrane protein 16A/anoctamin-1 (TMEM16A/ANO1), chloride channels, and proarrhythmic safety risks. Additionally, we highlight unresolved challenges, including bias in artificial intelligence models, incomplete conformational sampling, assay interference, organoid heterogeneity, and regulatory acceptance of MPS platforms. This review proposes a staged decision framework in which computational prioritization, scalable functional screening, direct electrophysiological confirmation, safety pharmacology, DMPK assessment, and disease-relevant human models serve as complementary filters rather than competing platforms for the identification of selective and translatable ion-channel therapeutics. Full article

Hysteresis seems to play a critical role in the generation and modulation of electrical signal events in neurons, muscles, and other excitable tissues. In voltage-gated ion channels, hysteretic conductance manifests under cycling changes in transmembrane voltage when conductance is delayed in response to voltage changes. Such dynamic behavior emerges naturally when the frequency of the oscillatory voltage becomes comparable to the characteristic relaxation time associated with transitions between channel conductance states and is reminiscent of hysteresis observed in transistors, memristors or solar cells. To investigate this delayed response, various discrete-state Markov models have been proposed. In these frameworks, an ion channel is represented as a finite set of states—typically corresponding to closed and open conformations—with transitions governed by voltage-dependent rates. As an alternative, the progress of activation and transition between opening and closing states of a channel is described in terms of a diffusive, collective “reaction coordinate” which fulfills a Langevin equation and the Smoluchowski–Fokker–Planck equation associated with it. Here we review this approach in modeling dynamic memory of ion channels. Full article

Electrocardiographic imaging (ECGI) is a noninvasive technique for reconstructing cardiac electrical activity by recording body-surface potentials and geometric information of the heart and torso. The ECGI forward problem is the cornerstone of ECGI. Depending on the forward model, ECGI can reconstruct epicardial/endocardial surface potentials, activation/recovery sequences, transmembrane voltages, and other electrophysiological quantities of interest. This article reviews the modeling process and research progress of forward modeling. This review systematically summarizes the mathematical methods used in the ECGI forward problem by classifying them into three representative models: the cardiac surface potential (CSP), equivalent double-layer (EDL), and transmembrane voltage (TMV) models, with detailed derivations and guidance on their practical applications. Full article

We examine the effects from small, spatially localized permanent charges on ionic transport in narrow membrane channels. Our analysis is based on a one-dimensional steady-state Poisson–Nernst–Planck (PNP) model involving two oppositely charged ion species with constant diffusion coefficients under electroneutral boundary conditions. In the framework of geometric singular perturbation theory, the steady PNP system is reformulated as a fast–slow dynamical system amenable to boundary-layer analysis. In the limit of vanishing permanent charge, the solution exhibits a singular structure with sharp boundary-layer segments and smooth bulk segments across regions of piecewise constant charge. Assuming the permanent charge strength Q is small, we carry out a regular perturbation expansion about $Q=0$ and derive explicit first-order corrections to each ion’s flux. Closed-form expressions are obtained for both the leading-order (zero-charge) fluxes and the $O\left(Q\right)$ flux corrections, revealing how even a small fixed charge can modulate the magnitude of individual ionic fluxes as a function of the applied transmembrane voltage and boundary concentration asymmetry. These results elucidate how permanent charge enhances or inhibits specific ionic flows, thereby influencing channel selectivity. Overall, our analysis provides clear asymptotic formulas and highlights the broader relevance of this perturbative approach to electro-diffusive transport modeling in biophysical systems. Full article

Bactrocera dorsalis Hendel is a devastating invasive pest that costs billions of dollars in agricultural losses worldwide. Current control strategies rely heavily on male-specific attractants such as methyl eugenol, which are less effective against females, underscoring the need for female-targeted control approaches. Here, we investigated the molecular mechanisms underlying female attraction to cis-linalool oxide by functionally characterizing the odorant receptor OR45a, identifying it as a molecular target for female-oriented pest management. We conducted spatiotemporal expression analysis of OR45a in response to cis-linalool oxide, followed by RNAi and behavioral assays. Phylogenetic analysis of OR45a orthologs from 10 Dipteran species, combined with structural topology prediction and solvent-accessible surface area (ASA) analysis, helped identify functional domains and residues. Site-directed mutagenesis and two-electrode voltage clamp (TEVC) recordings validated receptor–ligand interactions. Results showed that OR45a was specifically upregulated in antennae, with peak expression at 10 days post-eclosion, coinciding with oviposition periods. RNAi significantly reduced OR45a transcript levels and female behavioral responses to cis-linalool oxide. Phylogenetic analysis showed that OR45a is highly conserved within Tephritidae but diverges from Drosophilidae, with closest similarity to Anastrepha ludens, indicating ecological specialization. Structural modeling predicted a canonical seven-transmembrane architecture with three extracellular loops forming the ligand-binding pocket. Among five key residues identified, Leu122 and Ile146 were essential for ligand recognition, while Tyr107 contributed to protein stability. These findings reveal a female-specific odorant receptor mechanism in B. dorsalis and provide molecular targets for OR45a-based attractants, addressing a critical gap in female-focused pest management. Full article

Background/Objectives: Potassium (K⁺) channels are essential transmembrane proteins that regulate ion flow, playing a critical role in regulating action potentials and neuronal transmission. Although K⁺ channel openers (agonists, K⁺ Ag) are widely used in treating neurological and psychiatric disorders, their precise mechanisms of action remain unclear. Our study explored how K⁺ channel openers might influence the expression of voltage-gated K⁺ channels (Kv) in rat brain. Methods: Briefly, eight rats per group received intraperitoneal injections of diazoxide (Dia), chlorzoxazone (Chl), or flupirtine (Flu). Two hours post-injection, the prefrontal cortex (PFC), nucleus accumbens (NAc), dorsal striatum (dSTR), dorsal hippocampus (dHIP), and ventral hippocampus (vHIP) were collected for mRNA expression analysis of various Kv. Results: Dia administration altered expression of Kcna6 in the NAc, dSTR, and vHIP, and Kcnq2 in the PFC, dSTR, and dHIP. The mRNA levels of Kcna2 and Kcna3 changed in the NAc, dHIP, and vHIP, while Kcna6 expression increased in the PFC, dHIP, and vHIP of rats treated with Chl. Injection of Flu resulted in altered expression for Kcna1 in the NAc, dSTR, and dHIP; Kcna3 in the PFC, NAc, dHIP, and vHIP; Kcna6 in the dSTR, dHIP, and vHIP; and Kcnq2 and Kcnq3 in the PFC, dHIP, and vHIP. We also found dose-dependent changes. Conclusions: To our knowledge, this is the first study to identify the effects of potassium channel openers on gene expression within the mesocorticolimbic and nigrostriatal dopaminergic systems. These findings reveal a novel molecular mechanism underlying the action of these drugs in the brain. Importantly, our results have broader implications for translational neuroscience, particularly in the context of repurposing FDA-approved drugs, such as diazoxide and chlorzoxazone, for the treatment of neurological disorders. Full article

Optical mapping, nanotechnology-based multielectrode arrays and automated patch-clamp allow transmembrane voltage mapping with high spatial resolution, as well as L-type calcium and inward rectifier currents measurements using native mammalian cardiomyocytes. However, these methods are limited to in vitro and ex vivo experiments, while magnetocardiography (MCG) might offer a novel approach for non-invasive preclinical safety assessments of new drugs in intact and even conscious rodents by reconstructing the ventricular action potential waveform (rVAPw) from MCG signals. Objective: This study aims to assess the feasibility of rVAPw reconstruction from MCG signals in Guinea pigs (GPs) and validate the results by comparison with simultaneously recorded epicardial ventricular monophasic action potentials (eVMAP). Methods: Unshielded MCG (uMCG) data of 18 GPs, investigated anaesthetized and awake at ages of 5, 14, and 26 months using a 36-channel DC-SQUID system, were analyzed to calculate rVAPw from MCG’s current arrow map. Results: Successful rVAPw reconstruction from averaged MCG showed good alignment with eVMAP waveforms. However, some rVAPw displayed incomplete or distorted repolarization at sites with lower MCG amplitude. Conclusions: 300-s uMCG averaging allowed rVAPw reconstruction in intact GPs. Occasionally distorted rVAPw suggests the need for dedicated MCG devices development, with higher density of optimized vector sensors, and modelling tailored for small animal hearts. Full article

Modeling ion transport through membrane channels is crucial for understanding cellular processes, and Poisson–Nernst–Planck (PNP) equations provide a fundamental continuum framework for such ionic fluxes. We investigate a quasi-one-dimensional steady-state PNP system for two oppositely charged ion species, focusing on how large permanent charges within the channel and realistic boundary conditions impact ion transport. In contrast to classical models that impose ideal electroneutrality at the channel ends (a simplification that eliminates boundary layers near the membrane interfaces), we adopt relaxed neutral boundary conditions that allow small charge imbalances at the boundaries. Using asymptotic analysis treating the large permanent charge as a singular perturbation, we derive explicit first-order expansions for each ionic flux, incorporating boundary layer parameters $(\sigma ,\rho )$ to quantify slight deviations from electroneutrality. This analysis enables a qualitative characterization of individual cation and anion flux behaviors. Notably, we identify two critical transmembrane potentials, $V_{1c}$ and $V_{2c}$, at which the cation and anion fluxes, respectively, vanish, signifying flux-reversal thresholds that delineate distinct monotonic regimes in the flux-voltage response; these critical values depend on the permanent charge magnitude and the boundary layer parameters. We further show that both ionic fluxes exhibit saturation: as the applied voltage becomes extreme, each flux approaches a finite limiting value, with the saturation level modulated by the degree of boundary charge imbalance. Moreover, allowing even small boundary charge deviations reveals non-intuitive discrepancies in flux behavior relative to the ideal electroneutral case. For example, in certain parameter regimes, a large permanent charge that enhances an ionic current under strict electroneutral conditions will instead suppress that current under relaxed-neutral conditions (and vice versa). This new analytical framework exposes subtle yet essential nonlinear dynamics that classical electroneutral assumptions would otherwise obscure. It provides deeper insight into the interplay between large fixed charges and boundary-layer effects, emphasizing the importance of incorporating such realistic boundary conditions to ensure accurate modeling of ion transport through membrane channels. Numerical simulations are performed to provide more intuitive illustrations of our analytical results. Full article

Contactin-associated protein-like 2 (CASPR2) is a transmembrane protein of the neurexin superfamily, essential for clustering voltage-gated potassium channels, particularly Kv1, at the juxtaparanodal regions of myelinated axons. This precise localisation is essential for maintaining normal axonal excitability and preventing aberrant signal propagation. Autoantibodies targeting CASPR2 have been associated with various neurological syndromes, notably peripheral nerve hyperexcitability (PNH), which presents clinically with neuromyotonia and myokymia. PNH is characterised by distinctive electrophysiological findings, including neuromyotonic discharges, myokymic discharges, and afterdischarges, which provide diagnostic value and insight into underlying pathophysiology. This review explores the mechanisms of anti-CASPR2-associated PNH, focusing on how antibody-mediated disruption of Kv1 channel clustering leads to altered axonal excitability. Current evidence suggests that both the distal and proximal segments of the axon are sites of pathological activity, where impairments in action potential termination and re-entry prevention result in spontaneous, repetitive discharges. While afterdischarges likely originate within the axon, the precise location—whether in the alpha-motoneuron soma or axon—is uncertain. The involvement of spinal inhibitory circuits has also been proposed, though it remains speculative. Understanding the neurophysiological features of anti-CASPR2-associated PNH is essential for improving diagnostic accuracy and guiding treatment strategies. Further research is needed to clarify the mechanisms of CASPR2-related hyperexcitability. Full article

The family of voltage-dependent anion channels (VDACs) comprises three isoforms (VDAC-1, VDAC-2, VDAC-3). VDACs have been extensively described as localised in the outer mitochondrial membrane where they are involved in the exchange of ions, metabolites, and ATP/ADP between mitochondria and cytosol. The VDAC interacts with disease-specific proteins and thus regulates the mitochondrial function and controls the cellular energy resources, explaining its involvement in cell death and apoptosis. In addition, VDAC-1 and -2 can also be found at other cellular locations such as in the sarcoplasmic reticulum, in the endoplasmic reticulum, as well as in the plasma membrane. Through single-channel pore regulation, oligomerisation, or changed expression levels the VDAC is involved in different neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, Amyotrophic lateral sclerosis, Huntington’s disease, and others. Here, we critically summarise current discussions about the VDAC as a common key player for these diseases. We suggest that the VDAC acts as a transmembrane multifunctional regulatory protein which might serve as a pharmacological target for the development of novel drugs against neurodegenerative diseases such as the application of recombinant antibody technology. Full article

Mammalian spermatozoa undergo a series of physiological and biochemical changes in the oviduct that lead them to acquire the ability to fertilize eggs. During their transit in the oviduct, spermatozoa face a series of environmental changes that can affect sperm viability. A series of ion channels and transporters, as well as the sperm cytoskeleton, allow spermatozoa to remain viable and functional. Cl⁻ channels such as TMEM16A (calcium-activated chloride channel), CFTR (cystic fibrosis transmembrane conductance regulator), and ClC3 (chloride voltage-gated channel 3) are some of the ion transporters involved in maintaining cellular homeostasis. They are expressed in mammalian spermatozoa and are associated with capacitation, acrosomal reaction, and motility. However, little is known about their role in maintaining sperm volume. Therefore, this study aimed to determine the mechanism through which TMEM16A maintains sperm volume during capacitation. The effects of TMEM16A were compared to those of CFTR and ClC3. Spermatozoa were capacitated in the presence of specific TMEM16A, CFTR, and ClC3 inhibitors, and the results showed that only TMEM16A inhibition increased acrosomal volume, leading to changes within the acrosome. Similarly, only TMEM16A inhibition prevented actin polymerization during capacitation. Further analysis showed that TMEM16A inhibition also prevented ERK1/2 and RhoA activation. On the other hand, TMEM16A and CFTR inhibition affected both capacitation and spontaneous acrosomal reaction, whereas ClC3 inhibition only affected the spontaneous acrosomal reaction. In conclusion, during capacitation, TMEM16A activity regulates acrosomal structure through actin polymerization and by regulating ERK1/2 and RhoA activities. Full article

Voltage-gated Ca²⁺ (Ca_V) channels are transmembrane proteins comprising the pore-forming subunit Ca_Vα₁ and the ancillary proteins Ca_Vα₂δ and Ca_Vβ. They are expressed in various tissues, including the nervous system, where they regulate Ca²⁺ entry in response to membrane potential changes. The increase in intracellular Ca²⁺ allows for regulating cell excitability and releasing neurotransmitters, among other cellular events. Leucine-rich repeat kinase 2 (LRRK2) is a serine–threonine kinase involved in vesicular mobilization. Previously, it has been shown that LRRK2 regulates neurotransmission by phosphorylating the Ca_Vβ auxiliary subunit of the Ca_V2.1 (P/Q-type) presynaptic channels. However, it is unknown whether the kinase can regulate the activity of other Ca_V channel subtypes, such as Ca_V1.3 (L-type), which play a significant role in the excitability of dopaminergic neurons in the substantia nigra pars compacta (SNc) and whose dysregulation contributes to neurodegeneration in Parkinson’s disease (PD). Here, we found potential phosphorylation sites for LRRK2 in Ca_Vβ₃ and examined how these molecules interact. We used immunoprecipitation and electrophysiology in HEK-293 cells expressing recombinant Ca_V1.3 channels, both with and without wild-type LRRK2 or its LRRK2^G2019S mutation, which plays a role in familial PD through a possible gain-of-toxic-function mechanism. Our results show that LRRK2^G2019S significantly increases current density through Ca_V1.3 channels, and this effect depends on the presence of Ca_Vβ₃. Site-directed mutagenesis revealed that phosphorylation at S152 in the sequence of Ca_Vβ₃ is necessary and sufficient to explain the abnormal regulation of the channels mediated by LRRK2^G2019S. These data provide new insights into the molecular regulation that mutant LRRK2 may exert on L-type Ca_V1.3 channels, which determine pacemaker activity in dopaminergic neurons of the SNc and may, therefore, play a relevant role in the molecular pathophysiology of PD. Full article

Voltage-gated sodium (Nav) channels play a crucial role in initiating and propagating action potentials throughout the heart, muscles and nervous systems, making them targets for a number of drugs and toxins. While patch-clamp electrophysiology is considered the gold standard for measuring ion channel activity, its labor-intensive and time-consuming nature highlights the need for fast screening strategies to facilitate a preliminary selection of potential drugs or hazards. In this study, a high-throughput and cost-effective biosensing method was developed to rapidly identify specific agonists and inhibitors targeting the human Nav1.1 (hNav1.1) channel. It combines a red fluorescent dye sensitive to transmembrane potentials with CHO cells stably expressing the hNav1.1 α-subunit (hNav1.1-CHO). In the initial screening mode, the tested compounds were mixed with pre-equilibrated hNav1.1-CHO cells and dye to detect potential agonist effects via fluorescence enhancement. In cases where no fluorescence enhancement was observed, the addition of a known agonist veratridine allowed the indication of inhibitor candidates by fluorescence reduction, relative to the veratridine control without test compounds. Potential agonists or inhibitors identified in the initial screening were further evaluated by measuring concentration–response curves to determine EC₅₀/IC₅₀ values, providing semi-quantitative estimates of their binding strength to hNav1.1. This robust, high-throughput biosensing assay was validated through comparisons with the patch-clamp results and tested with 12 marine toxins, yielding consistent results. It holds promise as a low-cost, rapid, and long-term stable approach for drug discovery and non-target screening of neurotoxins. Full article